Developer docs
API playgroundTry for free, no card

Search company profiles

Ramona

Full company profile

uuid00006zd

Namestring
Ramona
Legal namestring
Ramona Optics, Inc.
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Ramona Optics, Inc. is a privately held biotechnology instrumentation company headquartered in Durham, North Carolina (incorporated in Delaware) that develops high-throughput microscopy tools built around its proprietary MCAM (Multi-Camera Array Microscope) platform. The MCAM architecture uses 24 or 48 micro-cameras operating in parallel to capture entire well plates simultaneously rather than scanning sequentially, delivering quoted throughput up to 24x faster than conventional microscopes — with the company stating capacity for 1,000 plates per day at 1,000 conditions per plate. All systems are compatible with standard SBS well plates (6–1,536 wells) and include a formal Web API for robotic lab integration.

The company sells three integrated products: Vireo™ (a live-cell imaging system for cells and organoids launched at SLAS2025), Kestrel™ (an imaging system for small model organisms including zebrafish at video rates above 150fps), and MCAM™ Software (an AI-powered multiwell analysis platform using Vision Transformers, automated segmentation, and 10x video compression). Research-stage extensions include PANORAMA, FiLM-Scope, and ReFLeCT platforms published in 2025, plus Momentum™ workflow scheduling software for longitudinal studies. The technology originated from computational microscopy research at Duke University by the founders, and the company has received sustained SBIR/STTR support from NIH, NCI, NSF, and NIBIB.

Ramona generates revenue through one-time capital equipment sales of Vireo and Kestrel systems, recurring software platform access, and professional services including installation, training, and field application scientist support. Pricing is quote-based with multi-year enterprise contracts, delivered via direct enterprise field sales with a prominent "Book a Demo" CTA and active participation at conferences such as SLAS, AACR, SOT, and the International Zebrafish Conference. Customers span pharmaceutical and biotech firms (including Regeneron), academic universities (UNC, Oregon State, NC State, UCSF, University of Chicago), government research institutions, and contract research organizations. A March 2026 SEC Form D filing indicates $26M+ raised of a $31M equity offering from 32 investors to fund working capital as the company scales commercial operations.

Short descriptiontext

Ramona Optics develops proprietary MCAM (Multi-Camera Array Microscope) imaging systems and AI-powered analysis software, serving pharmaceutical, biotech, academic, and government research customers with high-throughput live-cell and small model organism imaging at up to 24x conventional speeds.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
high-throughput microscopy, live-cell imaging systems, multi-camera array microscopy, drug screening imaging, organoid imaging instruments
Industry2 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Optical Instruments & Lenses3827
Product category
Scientific Microscopy Instrumentation
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Systems Sales
TypeOne Time License
Description

Sale of Vireo and Kestrel microscope systems. These are high-value capital equipment instruments priced as complete systems with varying configurations. Systems include integrated hardware and proprietary software.

ramonaoptics.com
2MCAM Software Platform
TypeSubscription Recurring
Description

AI-powered multiwell image analysis software platform sold as part of system packages or potentially separately. Includes real-time data processing, advanced visualization, and machine learning tools for image capture and data featurization.

ramonaoptics.com
3Professional Services & Support
TypeProfessional Services
Description

Installation, training, and ongoing technical support services for microscope systems. Field application scientists provide onboarding and optimization support.

ramonaoptics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Enterprise microscope systems with custom pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Ramona sells complete Vireo and Kestrel systems with pricing tailored to specific customer research requirements. Contact sales for quote.

ramonaoptics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Vireo™
Description

World's fastest live-cell imaging system - a 4D imaging system with MCAM Technology for studying cells and organoids.

ramonaoptics.com
+3 more records
Core offering1 text field

Ramona develops and sells high-throughput microscopy instruments powered by its proprietary MCAM (Multi-Camera Array Microscope) technology, which uses 24 parallel micro-cameras to image entire well plates simultaneously rather than sequentially. Its commercial product line includes the Vireo™ live-cell imaging system, the Kestrel™ small model organism imaging system, and the MCAM™ Software platform for AI-powered multiwell image analysis, sold primarily to pharmaceutical companies, biotech firms, government research entities, and academic universities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 24x throughput increase across wells - entire 96-well plate imaged in 30 seconds (4X) or 2 minutes (10X)
+5 more records
Product overview1 text field

Ramona offers a unified product portfolio centered on high-throughput live-cell imaging. The core offering consists of three integrated products: Vireo™ (world's fastest live-cell imaging system for cells and organoids), Kestrel™ (imaging system for small model organisms including zebrafish), and MCAM™ Software (AI-powered multiwell image analysis platform). All products are powered by Ramona's proprietary MCAM™ (Multi-Camera Array Microscope) technology featuring 24-camera parallel imaging. The portfolio solutions for teams tackling quality control, high-throughput drug screening, and real-time cellular dynamics with precision and speed.

Product and service4 records
1Vireo™
CategoryLive-cell imaging instrument
Description

The world's fastest live-cell imaging system that uses MCAM Technology for 4D imaging of cells and organoids, delivering 1-minute per plate processing, 24x parallelized video capture, and multi-channel fluorescence for non-destructive assessment of cellular function and dynamics.

2Kestrel™
CategorySmall model organism imaging instrument
Description

The ultimate imaging system for small model organisms that performs high-throughput behavioral, morphological, and fluorescence analysis of entire plates of zebrafish and other model organisms at video rates above 150fps.

3MCAM™ Software
CategoryImaging analysis software
Description

AI-powered multiwell image analysis platform that streamlines high-throughput imaging with an automation API, real-time machine learning analysis, Vision Transformer-based video encoding, and tools to translate image data into quantifiable metrics.

4Momentum™ Workflow Scheduling Software
CategoryWorkflow scheduling software
Description

Workflow scheduling software for the MCAM platform that enables revisiting well plates over prolonged periods to support longitudinal studies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Gregor Horstmeyer (CEO Signatory)
Strategic tierCoreTypeOthersAnnounced on2026-03-01
Description

Gregor Horstmeyer serves as CEO and signed the March 2026 SEC Form D filing as the authorized signatory of Ramona Optics, Inc.

sec.gov
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Sells a broad portfolio of life-science microscopy and cell-imaging instruments (e.g., Evos, CellInsight, DMI8) and offers wider workflow solutions; not specialized to Ramona's parallel-camera architecture but a major incumbent in lab imaging.

TypeDirect peer
Description

Spun off from PerkinElmer, Revvity sells the Opera Phenix and Operetta high-content screening systems that compete head-to-head with Ramona's Vireo for cell and organoid imaging in pharma drug discovery.

TypeEmerging player
Description

Provides imaging components (sCMOS cameras, NanoZoomer slide scanners) and is increasingly active in high-throughput cellular imaging. Component supplier overlap with Ramona's camera-array architecture and an emerging player in integrated HCS systems.

TypeBroad incumbent
Description

Provides advanced microscopy and cellular-analysis instruments (e.g., Vutara, Luxendo light-sheet). Adjacent to Ramona's high-content screening focus with broader structural and super-resolution capabilities.

TypeDirect peer
Description

Subsidiary of Danaher (via Fortive spin) that manufactures high-content screening microscopes including the ImageXpress platform — directly comparable high-throughput live-cell imaging systems sold to pharma and academic drug-screening labs.

6Carl Zeiss Microscopy
TypeBroad incumbent
Description

Sells high-end research microscopes (Celldiscoverer 7, Axio Observer, LSM) used in cell biology and screening; broader portfolio than Ramona and focused on premium research-grade imaging rather than plate-scale throughput.

7Nikon Instruments
TypeBroad incumbent
Description

Markets Eclipse Ti2-E and BioStation CT for live-cell imaging and high-content screening; overlaps with Ramona's pharma/biotech customer base but with broader, general-purpose microscope offerings.

TypeBroad incumbent
Description

Danaher-owned microscopy provider offering THUNDER, STELLARIS, and DMI8 systems. Competes in advanced live-cell imaging but lacks Ramona's parallel-camera high-throughput plate-imaging specialization.

TypeDirect peer
Description

Acquired BioTek and sells the Cytation series of imaging multimode readers and high-content screening systems, directly competing with Ramona's high-throughput plate-imaging workflow for pharma and academic screening.

TypeDirect peer
Description

Sells the CellVoyager CV8000 and CQ1 high-content screening microscopes — established parallel-imaging alternatives targeting the same drug-screening and 3D cell biology applications as Ramona's MCAM technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds17 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ramona

Scientific Microscopy Instrumentationramonaoptics.com

Ramona Optics develops proprietary MCAM (Multi-Camera Array Microscope) imaging systems and AI-powered analysis software, serving pharmaceutical, biotech, academic, and government research customers with high-throughput live-cell and small model organism imaging at up to 24x conventional speeds.

What Ramona does

Ramona Optics, Inc. is a privately held biotechnology instrumentation company headquartered in Durham, North Carolina (incorporated in Delaware) that develops high-throughput microscopy tools built around its proprietary MCAM (Multi-Camera Array Microscope) platform. The MCAM architecture uses 24 or 48 micro-cameras operating in parallel to capture entire well plates simultaneously rather than scanning sequentially, delivering quoted throughput up to 24x faster than conventional microscopes — with the company stating capacity for 1,000 plates per day at 1,000 conditions per plate. All systems are compatible with standard SBS well plates (6–1,536 wells) and include a formal Web API for robotic lab integration.

The company sells three integrated products: Vireo™ (a live-cell imaging system for cells and organoids launched at SLAS2025), Kestrel™ (an imaging system for small model organisms including zebrafish at video rates above 150fps), and MCAM™ Software (an AI-powered multiwell analysis platform using Vision Transformers, automated segmentation, and 10x video compression). Research-stage extensions include PANORAMA, FiLM-Scope, and ReFLeCT platforms published in 2025, plus Momentum™ workflow scheduling software for longitudinal studies. The technology originated from computational microscopy research at Duke University by the founders, and the company has received sustained SBIR/STTR support from NIH, NCI, NSF, and NIBIB.

Ramona generates revenue through one-time capital equipment sales of Vireo and Kestrel systems, recurring software platform access, and professional services including installation, training, and field application scientist support. Pricing is quote-based with multi-year enterprise contracts, delivered via direct enterprise field sales with a prominent "Book a Demo" CTA and active participation at conferences such as SLAS, AACR, SOT, and the International Zebrafish Conference. Customers span pharmaceutical and biotech firms (including Regeneron), academic universities (UNC, Oregon State, NC State, UCSF, University of Chicago), government research institutions, and contract research organizations. A March 2026 SEC Form D filing indicates $26M+ raised of a $31M equity offering from 32 investors to fund working capital as the company scales commercial operations.

Ramona firmographics

Firmographics
Name
Ramona
Legal name
Ramona Optics, Inc.
Website
https://ramonaoptics.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Ramona Optics develops proprietary MCAM (Multi-Camera Array Microscope) imaging systems and AI-powered analysis software, serving pharmaceutical, biotech, academic, and government research customers with high-throughput live-cell and small model organism imaging at up to 24x conventional speeds.
Ownership category
akta.pro rank

Ramona industry classification

Industry
Product category
Scientific Microscopy Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • High-throughput microscopy
  • Live-cell imaging systems
  • Multi-camera array microscopy
  • Drug screening imaging
  • Organoid imaging instruments

Where Ramona is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Ramona business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Hardware Systems Sales: Sale of Vireo and Kestrel microscope systems. These are high-value capital equipment instruments priced as complete systems with varying configurations. Systems include integrated hardware and proprietary software.
  2. MCAM Software Platform: AI-powered multiwell image analysis software platform sold as part of system packages or potentially separately. Includes real-time data processing, advanced visualization, and machine learning tools for image capture and data featurization.
  3. Professional Services & Support: Installation, training, and ongoing technical support services for microscope systems. Field application scientists provide onboarding and optimization support.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise microscope systems with custom pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Ramona product offering

Product offering

Core offering

Ramona develops and sells high-throughput microscopy instruments powered by its proprietary MCAM (Multi-Camera Array Microscope) technology, which uses 24 parallel micro-cameras to image entire well plates simultaneously rather than sequentially. Its commercial product line includes the Vireo™ live-cell imaging system, the Kestrel™ small model organism imaging system, and the MCAM™ Software platform for AI-powered multiwell image analysis, sold primarily to pharmaceutical companies, biotech firms, government research entities, and academic universities.

Product overview

Ramona offers a unified product portfolio centered on high-throughput live-cell imaging. The core offering consists of three integrated products: Vireo™ (world's fastest live-cell imaging system for cells and organoids), Kestrel™ (imaging system for small model organisms including zebrafish), and MCAM™ Software (AI-powered multiwell image analysis platform). All products are powered by Ramona's proprietary MCAM™ (Multi-Camera Array Microscope) technology featuring 24-camera parallel imaging. The portfolio solutions for teams tackling quality control, high-throughput drug screening, and real-time cellular dynamics with precision and speed.

Differentiator

Problem solved

Functional benefit

Brands

  • Vireo™: World's fastest live-cell imaging system - a 4D imaging system with MCAM Technology for studying cells and organoids.
  • Kestrel™
  • MCAM™ Software
  • MCAM™ (Multi-Camera Array Microscope)

Products and services

  • Vireo™ The world's fastest live-cell imaging system that uses MCAM Technology for 4D imaging of cells and organoids, delivering 1-minute per plate processing, 24x parallelized video capture, and multi-channel fluorescence for non-destructive assessment of cellular function and dynamics.
  • Kestrel™ The ultimate imaging system for small model organisms that performs high-throughput behavioral, morphological, and fluorescence analysis of entire plates of zebrafish and other model organisms at video rates above 150fps.
  • MCAM™ Software AI-powered multiwell image analysis platform that streamlines high-throughput imaging with an automation API, real-time machine learning analysis, Vision Transformer-based video encoding, and tools to translate image data into quantifiable metrics.
  • Momentum™ Workflow Scheduling Software Workflow scheduling software for the MCAM platform that enables revisiting well plates over prolonged periods to support longitudinal studies.

Quantifiable outcome

  • 24x throughput increase across wells - entire 96-well plate imaged in 30 seconds (4X) or 2 minutes (10X)
  • +5 more outcomes

Companies that use Ramona

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Ramona technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

Ramona partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Gregor Horstmeyer (CEO Signatory)coreOthers · 1 March 2026Gregor Horstmeyer serves as CEO and signed the March 2026 SEC Form D filing as the authorized signatory of Ramona Optics, Inc.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Ramona competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: Sells a broad portfolio of life-science microscopy and cell-imaging instruments (e.g., Evos, CellInsight, DMI8) and offers wider workflow solutions; not specialized to Ramona's parallel-camera architecture but a major incumbent in lab imaging.
  • Bruker: Provides advanced microscopy and cellular-analysis instruments (e.g., Vutara, Luxendo light-sheet). Adjacent to Ramona's high-content screening focus with broader structural and super-resolution capabilities.
  • Carl Zeiss Microscopy: Sells high-end research microscopes (Celldiscoverer 7, Axio Observer, LSM) used in cell biology and screening; broader portfolio than Ramona and focused on premium research-grade imaging rather than plate-scale throughput.
  • Nikon Instruments: Markets Eclipse Ti2-E and BioStation CT for live-cell imaging and high-content screening; overlaps with Ramona's pharma/biotech customer base but with broader, general-purpose microscope offerings.
  • Leica Microsystems: Danaher-owned microscopy provider offering THUNDER, STELLARIS, and DMI8 systems. Competes in advanced live-cell imaging but lacks Ramona's parallel-camera high-throughput plate-imaging specialization.

Direct peers

  • Revvity: Spun off from PerkinElmer, Revvity sells the Opera Phenix and Operetta high-content screening systems that compete head-to-head with Ramona's Vireo for cell and organoid imaging in pharma drug discovery.
  • Molecular Devices: Subsidiary of Danaher (via Fortive spin) that manufactures high-content screening microscopes including the ImageXpress platform — directly comparable high-throughput live-cell imaging systems sold to pharma and academic drug-screening labs.
  • Agilent Technologies (BioTek): Acquired BioTek and sells the Cytation series of imaging multimode readers and high-content screening systems, directly competing with Ramona's high-throughput plate-imaging workflow for pharma and academic screening.
  • Yokogawa Electric: Sells the CellVoyager CV8000 and CQ1 high-content screening microscopes — established parallel-imaging alternatives targeting the same drug-screening and 3D cell biology applications as Ramona's MCAM technology.

Emerging players

  • Hamamatsu Photonics: Provides imaging components (sCMOS cameras, NanoZoomer slide scanners) and is increasingly active in high-throughput cellular imaging. Component supplier overlap with Ramona's camera-array architecture and an emerging player in integrated HCS systems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Ramona social profiles

Digital presence

Ramona financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ramona leadership team

Management profile

Number of profiles

Profiles10 records

Ramona funding detail

Funding detail

Funding overview

Funding rounds17 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ramona M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ramona

What does Ramona do?

Ramona develops and sells high-throughput microscopy instruments powered by its proprietary MCAM (Multi-Camera Array Microscope) technology, which uses 24 parallel micro-cameras to image entire well plates simultaneously rather than sequentially. Its commercial product line includes the Vireo™ live-cell imaging system, the Kestrel™ small model organism imaging system, and the MCAM™ Software platform for AI-powered multiwell image analysis, sold primarily to pharmaceutical companies, biotech firms, government research entities, and academic universities.

Is Ramona a public or private company?

Ramona is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ramona founded?

Ramona was founded in 2017. It employs 101 to 250 people.

Where is Ramona based?

Ramona is headquartered in Durham, United States, in the North America region.

How does Ramona make money?

Three revenue lines are on record. Hardware Systems Sales are the primary driver. The others are MCAM Software Platform and professional Services & Support.

Who are Ramona's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Bruker, Carl Zeiss Microscopy, Nikon Instruments and Leica Microsystems. Direct peers are Revvity, Molecular Devices, Agilent Technologies (BioTek) and Yokogawa Electric. Hamamatsu Photonics is listed as an emerging player.

Does Ramona have an API?

Yes. Ramona offers a Formal Web API for automation integration. The Vireo product page states 'Automation Integration: Formal Web API' and 'Robot-ready - Compatible with scheduling software through a formal Web API.' The MCAM Software page mentions 'Automated imaging with WebMCAM API.' The API enables developers to build automated workflows and integrate Ramona systems into robotic and scheduling workflows for maximum throughput.

What industry is Ramona in?

Ramona's product category is Scientific Microscopy Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsStartup Sees Through Many EyesRamona, a startup co-founded by Duke biomedical engineering professor Roarke Horstmeyer, developed a microscopy platform that combines images from multiple small cameras. The company has deployed over 70 systems globally and recently closed a Series A round for $25 million. Horstmeyer said the funding will support further technology improvements for AI-assisted discovery.Photonics SpectraRamona Optics Raises $25M to Commercialize AI Microscopy TechRamona Optics closed a $25 million Series A financing round led by ARCH Venture Partners. The funding will support scaling commercial operations and advancing its multi-camera array microscopy technology, which the company says is the first gigapixel imaging engine for cellular-level detail over hundreds of square centimeters.citybizRamona Optics Closes $25M Series A Led by Arch Venture PartnersRamona Optics closed a $25 million Series A financing round led by Arch Venture Partners, with participation from multiple investors. The company develops multi-camera array microscopes for biopharma and biomedical use, and plans to use the capital for scaling operations and advancing its technology.Pulse 2.0Ramona Optics Raises $25 Million Series A Led By ARCH Venture PartnersRamona Optics raised $25 million in a Series A led by ARCH Venture Partners, with additional investors. The company will use the funds to expand commercial operations and develop its MCAM microscopy technology for biomedical research and drug discovery.RamonaopticsTurning Living Biology into Answers for the Age of AIRamona announced a $25 million Series A led by ARCH Venture Partners to fund its multi-camera array microscope for AI-driven drug discovery. The instrument captures entire 96-well plates at cellular resolution, with 24 cameras streaming in real time. The funding aims to scale production as FDA and NIH policies shift toward human-relevant models.BioSpaceRamona Optics Raises $25 Million Series A to Transform Biomedical Research with Massively Parallel MicroscopyRamona Optics closed a $25 million Series A financing round led by ARCH Venture Partners. The funds will support scaling commercial operations and advancing its MCAM microscopy technology. The company plans to expand on-platform assay capabilities and strategic partnerships.Venture Capital Access OnlineRamona Optics Raises $25 Million Series A to Transform Biomedical Research with Massively Parallel MicroscopyRamona Optics closed a $25 million Series A financing round led by ARCH Venture Partners. The funds will support scaling commercial operations and advancing its MCAM microscopy technology. The company plans to expand on-platform assay capabilities and strategic partnerships.CityAMPig farmer pivots to bite-sized falafels in weight loss trendCranswick, a food conglomerate founded by pig farmers, reported revenue of £3bn, up 9% year-on-year, with pre-tax profit rising 19% to £216m. Its Mediterranean arm, including falafel and hummus brands, drove growth as consumers seek calorie-conscious diets. The company is expanding capacity and range to meet demand for sharing and high-protein products.SecSEC FORM DRamona Optics, Inc., a Delaware-incorporated biotechnology company headquartered in Durham, North Carolina, filed a Form D notice with the SEC on March 11, 2026, for an exempt offering of equity securities under Rule 506(b). The offering has a total target amount of $31,037,360 USD, with $26,037,360 already sold to 32 investors and $5,000,000 remaining to be sold, with proceeds earmarked for working capital.PR NewswireRamona Unveils Vireo™: The World's Fastest Live-Cell Imaging SystemRamona has launched Vireo, a live-cell imaging system capable of analyzing an entire 96-well plate across five channels in under two minutes using miniaturized 4k video microscopes and real-time AI image processing, representing an order-of-magnitude improvement over existing solutions. The system is designed for drug discovery applications and enables dynamic live-cell assays that were previously impossible due to throughput limitations and photodamage risks. The product will debut at the SLAS2025 conference in San Diego from January 25-29, where it is a finalist for the SLAS2025 New Product Award.